Finn John 4
4 · Trius Therapeutics Inc · Filed Mar 18, 2013
Insider Transaction Report
Form 4
Finn John
Chief Scientific Officer
Transactions
- Sale
Common Stock
2013-03-15$7.10/sh−1,500$10,650→ 190,360 total(indirect: By Trust)
Holdings
- 1,782
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2012.
- [F2]Includes 343 shares acquired May 18, 2012 and 465 shares acquired November 20, 2012 pursuant to the Issuer's Employee Stock Purchase Plan.